Moreover, insulin signaling dysfunction in obesity caused by impaired binding of insulin-like growth factor-1 (IGF-1) to insulin receptors on osteoblasts also had a negative impact on bone remodeling [37, 38]. This evidence concerns the gene INSR and obesity due to melanocortin 4 receptor deficiency.